Related Experiment Video
Updated: Jun 18, 2026

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice
Published on: February 14, 2021
Mechanisms of blood pressure reduction by prolonged activation of the baroreflex
Radu Iliescu1, Thomas E Lohmeier
1Department of Physiology and Biophysics at the University of Mississippi Medical Center, Jackson, MS 39211, USA. riliescu@physiology.umsmed.edu
Abstract:
Recent technological advances have made the activation of the afferent limb of the baroreflex a viable therapeutic approach for lowering blood pressure. Experimental studies demonstrate sustained reductions in blood pressure in response to electrical baroreflex activation and initial results from clinical trials using device-based therapy for drug-resistant hypertension are promising. Although theoretically obvious at first glance, the mechanisms involved in the blood pressure lowering effect of baroreflex activation elude precise quantification, and experiments designed to investigate them invariably challenge preconceived notions and even dogmas. This paper is a brief overview of our current understanding of these mechanisms.
More Related Videos
Related Concept Videos
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hypertension and Regulation of Blood Pressure
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Antihypertensive Drugs: Action of β1 Blockers
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin II Receptor Blockers

